Entrada Therapeutics Inc (TRDA)
18.80
+0.75
(+4.16%)
USD |
NASDAQ |
Nov 22, 16:00
18.85
+0.05
(+0.27%)
After-Hours: 20:00
Entrada Therapeutics Revenue (TTM): 215.23M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 215.23M |
| June 30, 2024 | 239.40M |
| Date | Value |
|---|---|
| March 31, 2024 | 162.87M |
| December 31, 2023 | 129.01M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
129.01M
Minimum
Dec 2023
239.40M
Maximum
Jun 2024
186.63M
Average
189.05M
Median
Revenue (TTM) Benchmarks
| Catalyst Pharmaceuticals Inc | 460.48M |
| Vertex Pharmaceuticals Inc | 10.63B |
| Assembly Biosciences Inc | 28.33M |
| Sarepta Therapeutics Inc | 1.640B |
| Regenxbio Inc | 84.33M |